Similarly, V1bR antagonists have been investigated for the treatment of major depressive disorder (MDD), generalized anxiety disorder, and alcohol dependence, owing to their ability to attenuate hyperactive HPA axis signaling [113]. The gene discussed is AVPR1B; the disease is major depressive disorder.